STOCK TITAN

VerifyMe (VRME) Financials

VRME NASDAQ

Ticker history: VRME became OPNW (OpenWorld, Inc.) on .

FY2025 annual
Revenue $16.4M -32.3% YoY
Net Income -$4.9M n/m YoY
EPS (Diluted) -$0.39 n/m YoY
Free Cash Flow $585K -32.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VRME SEC filings page.

VerifyMe, Inc. (VRME) reported $16.4M in revenue for fiscal year 2025, down 32.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VRME FY2025

FY2025 shows a smaller, higher-gross-margin business whose operating structure still produces losses and relies on financing for investment.

The key earnings-quality split is that FY2025 reported a net loss of $4.9M while operating cash flow was positive at $603K. FY2024 showed the same pattern, with a net loss of $3.8M alongside operating cash flow of $871K; accounting losses therefore were not a direct measure of cash consumed by operations in either year, even though the operating model remained unprofitable.

Gross-margin expansion has not converted into operating profitability. FY2025 revenue was $16.4M and gross margin reached 38.6%, but operating margin fell 12.8 percentage points to -30.9%. The business retained more gross profit per sales dollar while its overall cost structure absorbed even more of it.

Operating cash flow of $603K nearly matched free cash flow of $585K, indicating little cash was tied up in capital expenditures. Yet investing cash flow was -$2.7M while financing cash flow was $3.7M, so reported financing inflows funded the broader investment outflow rather than operating cash alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 47 / 100
Financial Health Score (5 of 6 dimensions) 47/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of VerifyMe, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
87

VerifyMe, Inc. held $4.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $603K of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and VerifyMe, Inc. scores 87/100 among other emerging companies.

Dilution
50

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. VerifyMe, Inc. scores 50/100 on it among other emerging companies.

R&D Intensity
3

VerifyMe, Inc. spent $20K on research and development in fiscal year 2025, which was 0.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and VerifyMe, Inc. scores 3/100 among other emerging companies.

Revenue Progress
20

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. VerifyMe, Inc. scores 20/100 on it among other emerging companies.

Burn Trend
n/a

Not available for VerifyMe, Inc., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Balance Sheet
76

VerifyMe, Inc.'s cash, cash equivalents and investments came to $4.4M at the end of fiscal year 2025, against $2.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and VerifyMe, Inc. scores 76/100 among other emerging companies.

Piotroski F-Score Partial
4/8

VerifyMe, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Mixed
N/A

VerifyMe, Inc. reported a net loss of $4.9M while generating $603K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

VerifyMe, Inc. reported an operating loss of $5.1M against $214K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.9M
YoY-57.8%
QoQ+7.7%
5Y CAGR+72.8%

VerifyMe, Inc. generated $1.9M in revenue in Q2 2026. This represents a decrease of 57.8% from the same quarter a year earlier. Against the prior quarter it is up 7.7%.

EBITDA
-$408K
YoYn/m
QoQn/m

VerifyMe, Inc.'s EBITDA was -$408K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$505K
YoYn/m
QoQn/m
5Y CAGRn/m

VerifyMe, Inc. reported a net loss of $505K in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.04
YoYn/m
QoQn/m

VerifyMe, Inc. earned -$0.04 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$5.1M
YoY-16.1%
QoQ+44.7%
5Y CAGR-14.8%
10Y CAGR+37.1%

VerifyMe, Inc. held $5.1M in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding
13M
YoY+6.8%
QoQ+0.4%

VerifyMe, Inc. had 13M shares outstanding in Q2 2026. This represents an increase of 6.8% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
53.5%
YoY+18.3pp
QoQ-0.7pp
5Y change-25.5pp

VerifyMe, Inc.'s gross margin was 53.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 18.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Operating Margin
-29.1%
YoY-22.0pp
QoQ+14.1pp

VerifyMe, Inc.'s operating margin was -29.1% in Q2 2026, reflecting core business profitability. This is down 22.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.1 percentage points.

Net Margin
-26.5%
YoY-20.0pp
QoQ+11.8pp

VerifyMe, Inc.'s net profit margin was -26.5% in Q2 2026, showing the share of revenue converted to profit. This is down 20.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.8 percentage points.

Return on Equity
-5.1%
YoY-3.1pp
QoQ+1.5pp
5Y change+4.0pp

VerifyMe, Inc.'s quarterly ROE was -5.1% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Capital Allocation

None of these metrics is reported for Q2 2026.

VRME Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VRME quarterly income statement
MetricQ2'2610-QQ1'26S-4/AQ4'2510-QQ3'2510-QQ2'2510-QQ1'25S-4/AQ4'24S-4/AQ3'2410-Q
Revenue$1.9M-57.8%$1.8M-60.2%$2.4M-68.8%$5.0M-7.4%$4.5M-15.5%$4.5M-22.6%$7.7M-12.1%$5.4M-3.0%
Cost of Revenue$887K-69.7%$812K-72.6%$1.2M-76.7%$3.0M-16.4%$2.9M-10.2%$3.0M-15.3%$5.2M-10.2%$3.5M-0.5%
Gross Profit$1.0M-35.8%$960K-35.6%$1.2M-51.7%$2.1M+9.4%$1.6M-23.9%$1.5M-34.1%$2.4M-15.9%$1.9M-7.4%
R&D ExpensesN/AN/A$5K0.0%$5K0.0%$5K0.0%$5K-90.9%$5K-94.0%$5K0.0%
SG&A Expenses$815K+13.8%$1.0M+18.7%$1.2M+11.0%$669K-14.0%$716K-19.9%$856K-23.6%$1.1M+7.1%$778K-34.0%
Operating Income-$556Kn/m-$767Kn/m-$723Kn/m-$3.4Mn/m-$322Kn/m-$593Kn/m-$337K-588.4%-$2.9Mn/m
EBITDA-$408Kn/m-$635Kn/m-$592Kn/m-$3.2Mn/m-$36Kn/m-$307Kn/m-$30K-108.2%-$2.6Mn/m
Interest Expense$51K+59.4%$88K+300.0%$93Kn/m$67Kn/m$32Kn/m$22K0.0%-$81K-173.6%-$29K-422.2%
Net Income-$505Kn/m-$679Kn/m-$687Kn/m-$3.4Mn/m-$291Kn/m-$571Kn/m-$501K-25150.0%-$2.4Mn/m
EPS (Basic)-$0.04n/m-$0.05n/m-$0.05n/m-$0.26n/m-$0.02n/m-$0.05n/m-$0.05n/m-$0.23n/m
EPS (Diluted)-$0.04n/m-$0.05n/m-$0.05n/m-$0.26n/m-$0.02n/m-$0.05n/m-$0.05n/m-$0.23n/m
Diluted Shares (Avg)13M+5.7%13M+8.6%N/A13M+19.6%13M+23.5%12M+22.0%N/A11M+7.3%

Not reported in any period shown, so not listed: Income Tax.

VRME Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VRME quarterly balance sheet
MetricQ2'2610-QQ1'26S-4/AQ4'2510-QQ3'2510-QQ2'2510-QQ1'25S-4/AQ4'24S-4/AQ3'2410-Q
Total Assets$11.4M-33.6%$12.1M-29.1%$13.0M-19.0%$13.3M-10.6%$17.2M-2.1%$17.1M-4.5%$16.1M-22.4%$14.8M-21.1%
Current Assets$6.1M-21.8%$6.8M-10.7%$7.7M+21.5%$7.9M+63.4%$7.9M+54.3%$7.7M+46.9%$6.4M-17.2%$4.8M-14.2%
Cash & Equivalents$5.1M-16.1%$3.5M-38.3%$4.4M+54.2%$4.0M+53.5%$6.1M+109.2%$5.7M+107.2%$2.8M-6.9%$2.6M-11.3%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$41K0.0%$31K-34.0%$37K-5.1%$32K+68.4%$41K+78.3%$47K+46.9%$39K+2.6%$19K-54.8%
Accounts Receivable$558K-49.3%$818K-14.3%$857K-67.5%$1.1M-6.1%$1.1M-9.4%$955K-20.2%$2.6M-12.6%$1.2M-13.0%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$2.9M-26.6%$2.9M-26.6%$2.9M-26.6%$2.9M-26.6%$4.0M-25.2%$4.0M-24.9%$4.0M-25.9%$4.0M-24.9%
Total Liabilities$1.4M-47.9%$1.7M-29.1%$2.0M-65.4%$2.2M-52.5%$2.7M-48.3%$2.5M-55.4%$5.9M-28.4%$4.5M-34.1%
Current Liabilities$1.4M-26.5%$1.7M+5.5%$2.0M-52.2%$2.1M-23.1%$1.9M-33.8%$1.6M-41.0%$4.2M-17.5%$2.8M-23.9%
Non-Current Liabilities$0-100.0%$0-100.0%$0-100.0%$32K-98.2%$793K-66.2%$804K-70.3%$1.6M-46.8%$1.8M-45.5%
Long-Term DebtN/AN/AN/AN/AN/AN/AN/A$500K-50.0%
Total Equity$10.0M-30.9%$10.4M-29.1%$11.0M+7.6%$11.1M+8.0%$14.4M+17.8%$14.6M+18.2%$10.2M-18.5%$10.3M-13.6%
Retained Earnings-$91.8Mn/m-$91.3Mn/m-$90.6Mn/m-$89.9Mn/m-$86.5Mn/m-$86.2Mn/m-$85.7Mn/m-$85.2Mn/m

VRME Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VRME quarterly cash flow statement
MetricQ2'2610-QQ1'26S-4/AQ4'2510-QQ3'2510-QQ2'2510-QQ1'25S-4/AQ4'24S-4/AQ3'2410-Q
Operating Cash Flow-$291K-141.0%-$711Kn/m$54K-90.5%$243Kn/m$710K+90.9%-$404Kn/m$569K-32.5%-$10Kn/m
Depreciation & Amortization$148K-48.3%$132K-53.8%$131K-57.3%$281K-8.2%$286K-4.7%$286K-4.3%$307K+2.7%$306K+3.7%
Capital ExpendituresN/AN/A$11Kn/m$1K-50.0%N/AN/A$0-100.0%$2Kn/m
Free Cash FlowN/AN/A$43K-92.4%$242Kn/mN/AN/A$569K-32.3%-$12Kn/m
Investing Cash Flow$1.9Mn/m-$109Kn/m-$167Kn/m-$2.2Mn/m-$176Kn/m-$156Kn/m-$222Kn/m-$162Kn/m
Financing Cash Flow-$13Kn/m-$14K-100.4%$459Kn/m-$69Kn/m-$174Kn/m$3.4Mn/m-$178Kn/m-$125K-118.7%
Share BuybacksN/AN/A$0-100.0%$68Kn/mN/AN/A$17Kn/m$0n/m

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid.

VRME Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VRME quarterly financial ratios
MetricQ2'2610-QQ1'26S-4/AQ4'2510-QQ3'2510-QQ2'2510-QQ1'25S-4/AQ4'24S-4/AQ3'2410-Q
Gross Margin53.5%+18.3pp54.2%+20.7pp48.8%+17.3pp41.2%+6.3pp35.2%-3.9pp33.5%-5.8pp31.6%-1.4pp34.9%-1.6pp
Operating Margin-29.1%-22.0pp-43.3%-30.0pp-30.3%-25.9pp-68.2%-15.4pp-7.1%+2.9pp-13.3%-2.1pp-4.4%-5.2pp-52.8%-37.5pp
Net Margin-26.5%-20.0pp-38.3%-25.5pp-28.7%-22.2pp-66.7%-22.1pp-6.4%0.0pp-12.8%-3.2pp-6.5%-6.6pp-44.6%-28.0pp
Return on Equity-5.1%-3.1pp-6.5%-2.6pp-6.2%-1.3pp-30.2%-6.6pp-2.0%+0.8pp-3.9%+0.6pp-4.9%-4.9pp-23.6%-15.8pp
Return on Assets-4.4%-2.7pp-5.6%-2.3pp-5.3%-2.2pp-25.3%-8.9pp-1.7%+0.3pp-3.3%-0.2pp-3.1%-3.1pp-16.4%-11.4pp
Current Ratio4.32+0.3x3.94-0.7x3.82+2.3x3.70+2.0x4.06+2.3x4.66+2.8x1.500.0x1.74+0.2x
Debt-to-EquityN/AN/AN/AN/AN/AN/AN/A0.050.0x
Liabilities-to-Equity0.140.0x0.170.0x0.18-0.4x0.19-0.2x0.19-0.2x0.17-0.3x0.57-0.1x0.44-0.1x
Asset Turnover0.17-0.1x0.15-0.1x0.18-0.3x0.380.0x0.260.0x0.26-0.1x0.48+0.1x0.37+0.1x
FCF MarginN/AN/A1.8%-5.6pp4.8%+5.0ppN/AN/A7.4%-2.2pp-0.2%+2.2pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
VerifyMe, Inc. VRME FY2025 $16.4M -$4.9M -29.9% N/A 47/100
ADT Inc. ADT FY2025 $5.1B $596.0M 11.6% $7.2B 55/100
The Brink's Company BCO FY2025 $5.3B $199.7M 3.8% $4.7B 54/100
Brady Corporation BRC FY2026 $1.7B $205.4M 12.4% $3.4B 75/100
Bridger Aerospace Group Holdings, Inc. BAER FY2025 $122.8M $4.1M 3.4% $17.2M 43/100
BIO-key International, Inc. BKYI FY2025 $5.9M -$7.2M N/A $4.1M 35/100

Frequently Asked Questions

VerifyMe, Inc. (VRME) reported $16.4M in total revenue for fiscal year 2025. This represents a -32.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

VerifyMe, Inc. (VRME) revenue declined by 32.3% year-over-year, from $24.2M to $16.4M in fiscal year 2025.

No, VerifyMe, Inc. (VRME) reported a net loss of $4.9M in fiscal year 2025, with a net profit margin of -29.9%.

VerifyMe, Inc. (VRME) reported diluted earnings per share of -$0.39 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

VerifyMe, Inc. (VRME) had EBITDA of -$4.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

VerifyMe, Inc. (VRME) had a gross margin of 38.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

VerifyMe, Inc. (VRME) had an operating margin of -30.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

VerifyMe, Inc. (VRME) had a net profit margin of -29.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

VerifyMe, Inc. (VRME) has a return on equity of -44.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

VerifyMe, Inc. (VRME) generated $585K in free cash flow during fiscal year 2025. This represents a -32.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

VerifyMe, Inc. (VRME) generated $603K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

VerifyMe, Inc. (VRME) had $13.0M in total assets as of fiscal year 2025, including both current and long-term assets.

VerifyMe, Inc. (VRME) invested $18K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

VerifyMe, Inc. (VRME) invested $20K in research and development during fiscal year 2025.

Yes, VerifyMe, Inc. (VRME) spent $221K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

VerifyMe, Inc. (VRME) had 13M shares outstanding as of fiscal year 2025.

VerifyMe, Inc. (VRME) had a current ratio of 3.82 as of fiscal year 2025, which is generally considered healthy.

VerifyMe, Inc. (VRME) had a liabilities-to-equity ratio of 0.18 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

VerifyMe, Inc. (VRME) had a return on assets of -37.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

VerifyMe, Inc. (VRME) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

VerifyMe, Inc. (VRME) reported a net loss of $4.9M while generating $603K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

VerifyMe, Inc. (VRME) reported an operating loss of $5.1M against $214K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

VerifyMe, Inc. (VRME) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For VerifyMe, Inc. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top